New Drugs in Cancer Chemotherapy

Nonfiction, Health & Well Being, Medical, Medical Science, Pharmacology, Specialties, Oncology
Cover of the book New Drugs in Cancer Chemotherapy by , Springer Berlin Heidelberg
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783642815652
Publisher: Springer Berlin Heidelberg Publication: March 9, 2013
Imprint: Springer Language: English
Author:
ISBN: 9783642815652
Publisher: Springer Berlin Heidelberg
Publication: March 9, 2013
Imprint: Springer
Language: English

The Analog Potential in Cancer Chemotherapy in the United States and Japan S. K. Carter Northern California Cancer Program, 1801 Page Mill Road, Building B, Suite 200, USA - Palo Alto, CA 94304 The bilateral collaborative program in cancer research between Japan and the United States is one of the oldest programs of this type. It is sponsored in the United States by the National Cancer Institute [1], while in Japan the sponsoring organization is the Japan Society for the Promotion of Science. Annual symposia concerning treatment have been held and in recent years they have been published [2, 3]. Drug development in both Japan and the United States has evolved over the years to an increasing emphasis on second generation compounds. This has come about as a result of the initial successes of chemotherapy development. Many active structures have been uncovered and the armamentarium of the medical and pediatric oncologist has grown dramatically. The uncovering of an active structure provides an opportunity for analog synthesis and attempts at elucidating structure-activity relationships. It is hoped that the therapeutic index of active structures can be improved so as to achieve superior clinical results.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

The Analog Potential in Cancer Chemotherapy in the United States and Japan S. K. Carter Northern California Cancer Program, 1801 Page Mill Road, Building B, Suite 200, USA - Palo Alto, CA 94304 The bilateral collaborative program in cancer research between Japan and the United States is one of the oldest programs of this type. It is sponsored in the United States by the National Cancer Institute [1], while in Japan the sponsoring organization is the Japan Society for the Promotion of Science. Annual symposia concerning treatment have been held and in recent years they have been published [2, 3]. Drug development in both Japan and the United States has evolved over the years to an increasing emphasis on second generation compounds. This has come about as a result of the initial successes of chemotherapy development. Many active structures have been uncovered and the armamentarium of the medical and pediatric oncologist has grown dramatically. The uncovering of an active structure provides an opportunity for analog synthesis and attempts at elucidating structure-activity relationships. It is hoped that the therapeutic index of active structures can be improved so as to achieve superior clinical results.

More books from Springer Berlin Heidelberg

Cover of the book Benzodiazepine Receptor Ligands, Memory and Information Processing by
Cover of the book Frontiers in European Radiology by
Cover of the book Chemical Thermodynamics by
Cover of the book Vertigo by
Cover of the book The Silver Market Phenomenon by
Cover of the book The Sedimentology of Chalk by
Cover of the book Agricultural Applications by
Cover of the book Diverse Effects of Hypoxia on Tumor Progression by
Cover of the book Detection of Trapped Antihydrogen by
Cover of the book Law and Practice of Foreign Arbitration and Enforcement of Foreign Arbitral Awards in Pakistan by
Cover of the book Current Concepts of Bone Fragility by
Cover of the book Regulation of Sexual Conduct in UN Peacekeeping Operations by
Cover of the book NMR — From Spectra to Structures by
Cover of the book Hormones, Talent, and Career by
Cover of the book Factoring Ideals in Integral Domains by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy